Last updated on November 2017

Women with Cutaneous Lupus Erythematosus (CLE)


Brief description of study

Women with Cutaneous Lupus Erythematosus (CLE)

Detailed Study Description

A research study is evaluating an investigational medication for cutaneous lupus erythematosus (CLE), or lupus-specific skin lesions, in women.

This research study may be an option if you:
  • Are a female 18-75 years of age
  • Have been diagnosed with moderate to severe CLE
  • Have had an inadequate response or intolerance to prior treatment for CLE

Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication at no cost.

Clinical Study Identifier: TX12825

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

PMG Research of Wilmington

PMG Research of Wilmington
Wilmington, NC USA
  Connect »